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SUMMARY
Over the last two decades, morbidity and mortality from malaria and dengue fever among other pathogens are an increasing Public 
Health problem. The increase in the geographic distribution of vectors is accompanied by the emergence of viruses and diseases in 
new areas. There are insufficient specific therapeutic drugs available and there are no reliable vaccines for malaria or dengue, although 
some progress has been achieved, there is still a long way between its development and actual field use. Most mosquito control 
measures have failed to achieve their goals, mostly because of the mosquito’s great reproductive capacity and genomic flexibility. 
Chemical control is increasingly restricted due to potential human toxicity, mortality in no target organisms, insecticide resistance, 
and other environmental impacts. Other strategies for mosquito control are desperately needed. The Sterile Insect Technique (SIT) 
is a species-specific and environmentally benign method for insect population suppression, it is based on mass rearing, radiation 
mediated sterilization, and release of a large number of male insects. Releasing of Insects carrying a dominant lethal gene (RIDL) 
offers a solution to many of the drawbacks of traditional SIT that have limited its application in mosquitoes while maintaining its 
environmentally friendly and species-specific utility. The self-limiting nature of sterile mosquitoes tends to make the issues related 
to field use of these somewhat less challenging than for self-spreading systems characteristic of population replacement strategies. 
They also are closer to field use, so might be appropriate to consider first. The prospect of genetic control methods against mosquito 
vectored human diseases is rapidly becoming a reality, many decisions will need to be made on a national, regional and international 
level regarding the biosafety, social, cultural and ethical aspects of the use and deployment of these vector control methods. 
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INTRODUCTION
Arthropods act as vectors for many human agents that cause 
several diseases30. Over the last two decades, morbidity and mortality 
from malaria, dengue fever, West Nile Virus among other pathogens 
are an increasing Public Health problem. Malaria has been increasing 
due to deteriorating health systems, increased mosquito resistance to 
insecticides, parasite resistance to anti-malaria drugs and slow progress 
in vaccine development28. In 2008 malaria was endemic in 109 countries 
and almost 3.3 billion people were at risk worldwide. It is estimated 
that in 2008 there were 863,000 deaths from about 243 million cases40. 
Dengue fever, including dengue hemorrhagic fever and dengue shock 
syndrome, is a rapidly emerging arthropod-borne viral disease threatening 
one-third of the world’s population with an estimated 50-100 million new 
infections per year13,18,33,41. Aedes aegypti, the main dengue vector, is an 
invasive species spread inadvertently around the world by human trade 
and travel and it is now distributed widely in tropical and subtropical 
regions, most notably in urban environments where it has adapted to 
breed in artificial containers and refuse. Finding and treating sufficient 
numbers of mosquito breeding sites as a measure of control is extremely 
challenging or impossible even for the most well-funded and organized 
programs. 
The increase in the geographic distribution of vectors is accompanied 
by the emergence of viruses and diseases in new areas. There is currently 
no vaccine or specific therapeutic drug available for dengue; therefore, 
control focuses on the mosquito. Bed nets are largely ineffective against 
this day biting mosquito, making source reduction and space spraying 
the mainstays of control. New approaches and vector control tools are 
urgently needed11,24,26,31,39.
Mosquito control measures have failed to achieve their goals, 
mostly because of the mosquito’s great reproductive capacity and 
genomic flexibility36. These two characteristics are exemplified by two 
observations. First of all, mosquito and other insects are well-known 
for developing resistance to insecticides and its resistance has been 
reported in most major insect disease vectors and against every class 
of chemical insecticide and insecticidal crops30,34, and chemical control 
is increasingly restricted due to potential human toxicity, mortality in 
no target organisms, insecticide resistance, and other environmental 
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impacts22,37. The second is the existence of a variety of closely related 
species that form complexes of cryptic species, some of which seem to 
be undergoing speciation in the process of adapting to an environment 
modified by man10. Resistance to insecticides has led to serious mosquito 
control problems, contributing to the resurgence of mosquito-borne 
diseases.
In light of this type of problem, other strategies for mosquito control 
must be considered, including genetic control (use of sterile mosquitoes 
and related techniques). The sterile insect technique is a species-specific, 
effective and environmentally friendly technique of insect control that 
has been widely used, and has succeeded in controlling agricultural pests 
and, in certain cases, mosquito vectors12,35,42. The aim of this review is to 
revisit strategies of SIT-based genetic control of mosquito populations 
and the recent advances in molecular biology and field tests that promise 
to control vectored diseases.
STERILE INSECT TECHNIQUE (SIT)
The Sterile Insect Technique (SIT) is a species-specific and 
environmentally benign method for insect population control24,32. In 1955, 
KNIPLING proposed the concept of introducing sterile insects into the 
population as a form of controlling pests with agricultural importance. 
SIT is based on mass rearing, radiation mediated sterilization, and release 
of a large number of male insects into a given target area33 (Fig. 1). 
Any successful mating with the sterile insect will result in no offspring. 
If enough sterile insects are released the population will decline24,43. 
Reduction or elimination of vector populations will tend to reduce or 
eliminate transmission of vector-borne diseases and has been an effective 
method of disease control in many regions31.
One of the major advantages of SIT over other techniques, such as 
insecticides, larvicides, and breeding site removal is that the males are 
very good at seeking out females of the same species and the technique 
becomes more effective as the population is reduced3,5,42. The Sterile 
Insect Technique is amongst the most non-disruptive pest control 
methods. Unlike some other biologically-based methods, it is species 
specific, does not release exotic agents into new environments and does 
not even introduce new genetic material into existing populations as 
the released organisms are not self-replicating21. The paradigm for this 
methodology was the successful elimination of Cochliomyia hominivorax 
(the causing agent of myiasis) from Southern United States, Mexico, 
and Central America. This area is currently protected from reinvasion 
from South-American flies by means of a barrier in Panama consisting 
of only a few sterile flies. 
SIT ISSUES
A major difficulty with SIT as currently practiced is that the released 
sterile insects are required to compete for mates with wild insects8. The 
production process, however, and in particular the need to sterilize the 
insects by irradiation, causes a dramatic loss of competitive mating ability 
relative to wild type5,27. The magnitude of this problem varies from one 
species to another but the combination of these effects leads to a tenfold 
or greater reduction in effectiveness for some species1.
Another problem is that SIT relies on the release of large numbers 
of sterile insects, but in some cases the adult females may themselves 
be unwanted or even hazardous. Mass rearing facilities initially produce 
equal numbers of the two sexes, but generally try to separate and discard 
females before release5,15.
Due to the possibility of preferential mating between released 
sterile insects and the fact that released sterile females do not diminish 
populations, bisexual releases are far less effective and more expensive 
than male-only releases in introducing sterility into wild populations. 
For agricultural pests in which females cause no damage, sex separation 
systems are not essential, but highly desirable in terms of increased 
efficiency. For the early SIT programs for mosquitoes, especially Aedes 
aegypti, sexes were separated using differences in pupal size, principally 
to increase efficiency. Since released sterile females may repeatedly 
feed on humans and thus contribute to disease transmission, tolerance 
for females in releases by programs targeting vector species is likely 
to be much lower than for agricultural pests. For these vectors, SIT 
can, therefore, only be applied if some highly efficient way to exclude 
females is developed. It is surprising that, in the earliest comprehensive 
description of SIT against mosquito vectors, developing sex separation 
methods is given almost no mention. Several inventive methods for sex 
separation of mosquitoes based solely on naturally occurring biological 
differences between males and females have been used. These have had 
varying degrees of success and were implemented at different scales.
Highly successful, area-wide SIT programs have eliminated or 
suppressed a range of major veterinary and agricultural pests around 
the world. These programs can succeed on very large scales - the 
largest rearing facility alone produces around two billion sterile male 
Mediterranean fruit flies per week (~20 tons/week), primarily for use in 
California and Guatemala. For these pests, SIT is a proven, cost-effective 
strategy for eradication or suppression of target populations, or to protect 
areas against invasion or re-invasion.
For mosquitoes, the situation is much different, with variable 
successes and problems. About 20 field trials during the 1970s and 
1980s demonstrated that the SIT could also be made to work against 
mosquitoes10,23. For example, Anopheles albimanus was successfully 
controlled in a field trial in El Salvador, using chemo-sterilized 
mosquitoes25. The fundamental properties of SIT are still highly attractive 
for mosquito control. This has led to a resurgence of interest in recent 
years, with several research groups trying to circumvent some of the 
technical limitations which prevented conventional SIT from becoming 
Fig. 1 - Conventional SIT schedule: mass rearing of mosquitoes followed by manual sex 
separation to assure that exclusively males are to be sterilized by ionizing radiation and 
further released to mate with wild females resulting in no progeny. This procedure must be 
repeated each and every time.
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a widespread approach following the early trials. 
The use of SIT against mosquitoes is problematic, due mainly to the 
fitness costs and operational difficulty of irradiation, and the density-
dependent nature of the target mosquito populations4,31. Distribution of 
mosquitoes may also be more problematic than for current SIT target 
species, for example, Ceratitis capitata (Medfly) and Cochliomyia 
hominivorax (New World Screwworm), because adult mosquitoes are less 
robust and more likely to suffer damage during transit and release3,32,38.
IMPROVING SIT: THE RIDL SYSTEM
It is clear that an effective Genetic System Mechanism (GSM) would 
reduce the cost and increase the efficiency of a SIT program. Various 
female-killing and sex-sorting genetic systems have been developed. So 
far, all the GSMs brought into use in factory mass production have relied 
on the linking of a dominant selectable marker to the male determining 
chromosome5. These issues could be mitigated by the use of insects 
engineered to carry specific unique traits, including conditional genetic 
sterilization or lethality that removes the need for irradiation15. The ability 
to use recombinant DNA to molecularly engineer insects opens the door 
to a wide array of techniques to control pests and improve beneficial 
species and, in particular, create strains to improve biocontrol methods 
such as the sterile insect technique (SIT)19.
The RIDL (Release of Insects Carrying a Dominant Lethal Gene) 
system proposed by THOMAS et al. (2000) consists of introducing a 
lethal dominant gene that could be under control of a female-specific 
promoter, such as that of vitellogenin gene. Expression of the lethal 
gene could be inactivated by treatment with tetracycline, allowing a 
colony to be maintained. When male and female separation is required, 
tetracycline is removed from the system, causing the death of all females 
(Fig. 2). The RIDL system is centered on the expression of tTA, a fusion 
protein that combines sequence-specific tetracycline-repressible binding 
to tRe, a tetracycline-response element, to a eukaryotic transcriptional 
activator. In the absence of tetracycline, this protein will bind to the 
tRe sequence, activating transcription from a nearby minimal promoter5 
(Fig. 2). 
When preparing mosquitoes for release, the repressor is inactivated 
and the lethal gene is expressed, causing the death of all females. 
When mating with wild females, males homozygous for the lethal 
gene will produce heterozygous progenies, of which only males will 
survive. Releasing of Insects carrying a Dominant Lethal gene (RIDL 
technology) offers a solution to many of the drawbacks of traditional 
SIT that have limited its application in mosquitoes while maintaining its 
environmentally friendly and species-specific utility4. Transgenic males 
are homozygous for a dominant lethal gene. Mating with indigenous 
population results in offspring that are heterozygous for the lethal gene 
leading to the death of all females and hence eventual suppression of 
the population due to a decrease in its reproductive capacity (Fig. 3)20,38. 
Genetic control aims to achieve universal coverage by taking advantage 
of the male insect’s efficiency in locating and mating with females of 
the same species44. 
Insects engineered to carry a female-specific lethal (or otherwise 
incapacitating) gene could be used to remove females prior to 
release3,14,23,38. A system based on a lethal gene (RIDL)38 that acts late 
in development would prevent mosquitoes from becoming adults, the 
only harmful life stage, yet enable them to survive and compete at the 
larval stage, when density-dependent competition occurs. Modeling 
this system predicts that fewer male mosquitoes of a late-lethal strain 
need to be released as compared to those carrying an early-lethal gene 
or irradiated strain to achieve an equivalent level of control of a target 
population7,14,16,17,32,38. 
A female-lethal version of RIDL, with insects homozygous for one 
or more female-specific dominant lethal genetic constructs, has been 
constructed in several species14. F1 progeny of RIDL males and wild 
females inherit a dominant female-specific lethal gene; the F1 females 
die, thereby reducing the reproductive potential of the wild population, 
but the F1 males are viable and fertile. This provides a genetic sexing 
mechanism facilitating male only release, either by employing the 
female-lethal version of RIDL and withdrawing the repressor from the 
generation prior to release, or by combining a bisex-lethal system with 
female lethality (with an independent means of repressing or inducing 
lethality) to permit male only release of bisex-lethal strains designed to 
kill progeny of both sexes in the field (Fig. 3)5. 
ECONOMIC DEPENDENCE
Economic cost-benefit analysis, which is needed to support use 
of novel interventions, is difficult because of lack of reliable data 
on the economic burden of disease for dengue and other neglected 
tropical diseases, and because of uncertainty around development and 
Fig. 3 - RIDL system: once a stable strain of genetic modified mosquitoes with female specific 
lethal gene is obtained, all that is need is to mass rear and remove the genetic repressor 
(tetracycline), the lethal gene will kill all females leaving males ready to be released and 
mate with wild females.
Fig. 2 - tTA and the tetracycline-repressible expression system. The tetracycline-repressible 
transcriptional activator (tTA) protein is placed under a promoter control. When expressed, 
the tTA protein binds to a specific DNA sequence, tetO, driving expression from an adjacent 
minimal promoter which leads to expression of any sequence (the effector gene) placed 
under the control of this minimal promoter. The combined effect is that the effector gene is 
expressed in essentially the pattern of the promoter driving tTA. However, in the presence of 
low concentrations of tetracycline, the tTA protein does not bind DNA and so expression of 
the effector gene is prevented. (Modified from ALPHEY 2002)5.
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implementation costs. Ideally it would be possible to analyze not only 
the cost-effectiveness of the stand-alone novel strategy, but also to 
compare it with existing alternatives and to model its incorporation in 
integrated vector management (IVM) programs, and indeed integrated 
disease management programs including drugs and vaccines, where 
available40. 
RIDL FIELD TESTS
Several different genetic approaches to mosquito control are being 
developed. These include approaches that are: Self-Limiting - repeated 
or recurrent releases are necessary to maintain the genetic construct in 
the target population. To have a significant epidemiological effect it will 
usually be necessary to release relatively large numbers of mosquitoes 
(inundative releases). Self-Sustaining - releases need to occur only once 
or a few times, and the construct will increase in frequency of its own 
accord and maintain itself at high frequency. Releases can often be of 
relatively fewer mosquitoes (inoculative releases)40.
As genetics-based population suppression (self-limiting) moves 
from laboratory to field, the lack of a clear regulatory framework for 
field use of modified mosquitoes is a significant challenge. This issue is 
not restricted to developing countries, or to strategies dependent on the 
use of recombinant DNA technology. Once regulatory frameworks are 
in place, risk assessments and public consultation also will be lengthy 
processes due the novelty of technologies and lack of experience by 
regulating agencies. The route to implementation of control programs 
based on these technologies is not obvious40.
Some issues must be fulfilled before a large scale mosquito release: 
(a) adult males must be known to mate with wild females at the release 
site, since laboratory cage fitness and competitiveness experiments of 
males does not ensure mating with wild type females; (b) sex separation 
lines improve efficiency and the effect of releasing programs, and 
are essential for mosquito vectors; (c) releasing methods must be 
suitable for all weather conditions anticipated, and are established and 
tested before control release programs start; (d) while female sterility 
provides an indicator of mating frequency, vector density is a more 
relevant indicator of the control effect on disease transmission; (e) mass 
rearing levels must be stable before releases begin; (f) releases must be 
programmed for maximum effect into suppressed populations; (g) wide 
control areas with similar monitoring must be available for comparison 
during suppression strategies development; (h) dispersion and mating 
characteristics are essential factors for quality control to assess the fitness 
of release material; (i) isolation of the test areas must be conducted 
and demonstrated conclusively for all weather conditions reasonably 
expected; (j) independent monitoring is essential to demonstrate 
effectiveness before release programs; (k) political stability, and healthy 
relationships with the public, press and political entities are essential for 
sustainability of control efforts10.
The self-limiting nature of sterile insects (whether sterilized by 
radiation, Wolbachia/CI (IIT), or RIDL genetic engineering) tends to 
make the issues related to field use of these somewhat less challenging 
than for self-spreading systems characteristic of population replacement 
strategies (including Wolbachia - and gene driver-based replacement 
strategies). They are also closer to field use, so might be appropriate to 
consider first. WHO/TDR funding for capacity-building and guidance 
development and this technical consultation are all steps in the right 
direction40.
There have been significant advances in population method using 
strains of Aedes aegypti homozygous for a dominant lethal genetic 
system1,5. Efficacy testing of RIDL strains has already been carried out in 
laboratory and/or contained “semi-field” conditions in Brazil, Malaysia, 
Mexico and Cayman Islands9.
Under an envisioned RIDL release program, it would be important 
to detect any resistance in the pest population that was capable of 
having a significant detrimental impact on the program’s effectiveness 
in time to take remedial action. Our population dynamic models 
predict a clear change in the pattern of pest as such resistance begins 
to spread. A properly designed monitoring strategy would be alert to 
such changes. Wild-caught individuals could then be used to screen 
for cross-resistance against a panel of available RIDL strains that use 
different lethal mechanisms, so that operations (or further trials, if 
this occurred before full implementation) could switch to deploying 
an appropriate alternative RIDL line before significant lasting loss of 
efficacy could result2,7.
PERSPECTIVES
The prospect of genetic control methods against mosquito vectored 
human diseases is rapidly approaching a reality. With the potential 
of a promising additional method for dengue and or malaria disease 
control, many decisions will need to be made on a national, regional and 
international level regarding the biosafety, social, cultural and ethical 
aspects of the use and deployment of these vector control methods. 
A potential concern about releasing GM insects into the wild is 
that the inserted DNA may have unforeseen consequences. This has 
particularly been raised regarding strategies that aim to replace a wild 
population, for example with a version engineered to be unable to transmit 
a pathogen. One advantage claimed for genetic SIT strategies over 
population replacement strategies is that autocidal engineered insects are 
programmed to die and therefore the lethal genetic construct should die 
out if releases cease. This relies on the construct having some fitness costs 
even if it does not retain its efficacy. It has been shown that resistance to 
the construct might significantly increase its frequency. 
In theory, there are combinations of genetic properties of resistance 
for which the construct could eventually be driven to fixation; that 
scenario is highly unlikely to be played out in real life because the release 
program could be stopped if substantial resistance were detected, long 
before the RIDL construct became common, and the wild type would 
reinvade through immigration6.
Endemic disease countries need international guidance to assess 
the risks and benefits of using genetically modified mosquitoes. Since 
they may reach different conclusions about using these mosquitoes the 
World Health Organization (WHO) and its partners are in process to 
provide best practice guidance to the endemic countries on these issues 
(Mosqguide)29. Communicating mosquito and disease biology, and risks 
and benefits associated with specific novel control strategies, is resource 
intensive and has no obvious endpoint40. 
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RESUMO
Controle genético de mosquitos: estratégias de supressão de 
populações
Ao longo das duas últimas décadas, morbidade e mortalidade da 
malária e dengue e outros patógenos tem se tornado cada vez mais um 
problema de Saúde Pública. O aumento na distribuição geográfica de 
seus respectivos vetores é acompanhada pela emergência de doenças em 
novas áreas. Não estão disponíveis drogas específicas suficientes e não 
há vacinas específicas para imunizar as populações alvo. As medidas de 
controle de mosquitos atuais falharam em atingir os objetivos propostos, 
principalmente devido à grande capacidade reprodutiva dos mosquitos e 
alta flexibilidade genômica. O controle químico se torna cada vez mais 
restrito devido a sua potencial toxicidade aos seres humanos, mortalidade 
de organismos não alvos, resistência a inseticida além de outros impactos 
ambientais. Novas estratégias de controle são necessárias. A técnica 
do inseto estéril (SIT) é um método de supressão populacional espécie 
específico e ambientalmente amigável, baseia-se na criação em massa, 
esterilização mediante irradiação e liberação de um grande número de 
insetos machos. Liberar insetos carregando um gene letal dominante 
(RIDL) oferece uma solução a muitas limitações impostas pela técnica 
do inseto estéril (SIT) que limitaram sua aplicação em mosquitos e 
ainda assim mantém suas características de ambientalmente amigável 
e espécie específica. A natureza auto-limitante de mosquitos estéreis 
tende a deixar alguns empecilhos para uso no campo, de certa forma, 
menos desafiadores quando comparados a sistemas auto-propagação, 
característicos de estratégias de substituição de população. Sistemas 
auto-limitantes estão mais próximos para uso no campo, portanto pode 
ser apropriado considerá-lo primeiro. A perspectiva de métodos de 
controle genéticos contra mosquitos vetores de doenças que acometem 
humanos está rapidamente se tornando uma realidade, muitas decisões 
terão de ser tomadas em âmbito nacional, regional e internacional com 
relação a aspectos étnicos, sociais, culturais e de biossegurança para o 
uso e liberação destes métodos de controle de vetores.
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